- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
Regulatory Affairs in Emerging Markets
3 Days | 4 Key Emerging Regions
With the BRIC pharmaceutical market estimated to be valued in order of $60 billion, are you up-to-date on the strategies for successful market access and regulatory approval?
The emerging markets represent a huge potential for pharma companies. The growth of the middle-class population with access to quality healthcare represents a new customer base, combined with emerging markets being used as a low-cost base for outsourcing key research, development and regulatory functions.
Informa Life Sciences’ 2nd Annual Regulatory Affairs in Emerging Markets will provide you access to an experienced speaker panel, with first hand insights into strategies for successful market entry and case studies on regulatory approval in the Asia Pacific region, Latin America, Africa and the Middle East.
PROGRAMME UPDATES
Additional Latin America and MENA expert panellists announced!
Who You Will Meet...
Who You Will Meet...
Premnath Shenoy
Regulatory Affairs Director
AstraZeneca
|
Carsten Brockmeyer
Founder
Brockmeyer-Biopharma
|
Stefano Accorsi
Director, International Regulatory Affairs
Chiesi
|
Lisa Rysso-DeMaggio
President
RAQUELIAN Consulting
|
Global Sponsor
Sponsor
Media Partners
Featured Sessions...
- Regulatory landscape in Middle East and North Africa
- Submission requirements for Africa
- Optimising market entry in Asia Pacific
- Reviewing the regulatory landscape in Latin America
Must-attend biosimilars seminar
Evening seminar: Tuesday 18 October 2011
ANNOUNCING: NEW SEMINAR LEADER
Carsten Brockmeyer, Biosimilar Expert & Managing Director, Brockmeyer Biopharma, Germany
Successful registration of biosimilars in emerging markets
With biosimilar sales predicted to exceed $4 billion in BRICTM markets by 2016, and no formal regualtory strategy for biosimilar registration in these regions, can you ensure your share of this commerical potential?
Meet and network with more regulatory peers
Regulatory Affairs in Emerging Markets is co-located with Informa's NEW conference on e-Submissions. Visit www.informa-ls.com/esubmissions for more details!
Feeds | Like | Share    |
Dates and Venues
17 Oct 2011 - 19 Oct 2011
Crowne Plaza, Zurich, Switzerland
News/Articles
- Takeda rumoured to be interested in Cipla, Lupin units
- Sanofi makes OTC acquisition in India
- Latin America Diverges Widely on CMC Requirements; Harmonization Effort Continues Through PAHO
- Emerging markets growth stabilises Nycomed in Q2
- Argentina threatens companies with import controls
- China's updated ADR reporting rules to increase manufacturers' obligations
Regulatory Affairs in Russia and CIS
SAVE-THE-DATE
16-17 November 2011
Budapest | Hungary
Informa Life Sciences' 2nd Annual Conference on
Regulatory Affairs in Russia and CIS
To join the speaker panel or discuss session ideas, contact meera.byatt@informa.com
Contact us @ RA in EM
Event Registration:
Ph: +44 (0)20 7017 7823
E: registrations@informa-ls.com
Programme Information:
meera.byatt@informa.com
Sponsorship/Exhibition:
linda.cole@informa.com
